HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Snapir, A. Articles by Salonen, J. T. Search for Related Content PubMed PubMed Citation Articles by Snapir, A. Articles by Salonen, J. T.

CLINICAL STUDY: RISK FACTORS

An insertion/deletion polymorphism in the _2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events

Amir Snapir, MD^*, Paula Heinonen, MD^*, Tomi-Pekka Tuomainen, MD, Pia Alhopuro, BM^*, Matti K. Karvonen, MD^*, Timo A. Lakka, MD, Kristiina Nyyssönen, PhD, Riitta Salonen, MD, Jussi Kauhanen, MD, Veli-Pekka Valkonen, BM, Ullamari Pesonen, PhD^*, Markku Koulu, MD^*, Mika Scheinin, MD^* and Jukka T. Salonen, MD

^* Department of Pharmacology and Clinical Pharmacology, University of Turku, Turku, Finland
Research Institute of Public Health, University of Kuopio, Kuopio, Finland
Inner Savo Health Center, Suonenjoki, Finland

Manuscript received May 16, 2000; revised manuscript received December 18, 2000, accepted January 29, 2001.

Reprint requests and correspondence: Dr. Jukka T. Salonen, Research Institute of Public Health, University of Kuopio, P.O. Box 1627, FIN-70211 Kuopio, Finland
jukka.salonen{at}uku.fi

OBJECTIVES

Our aim was to study whether an insertion/deletion (I/D) polymorphism in the _2B-adrenoceptor gene is associated with the risk for cardiovascular diseases.

BACKGROUND

₂-adrenoceptors mediate contraction of vascular smooth muscle and induce coronary vasoconstriction in humans. The ₂-adrenoceptor subtype B mediates vasoconstriction in mice. A variant of the human _2B-adrenoceptor gene that encodes a D of three residues in an intracellular acidic motif has been shown to confer decreased receptor desensitization. This receptor variant could, therefore, be involved in diseases associated with enhanced vasoconstriction.

METHODS

This study was part of a prospective population-based study investigating risk factors for cardiovascular diseases in a cohort of middle-aged men from eastern Finland. Nine hundred twelve men aged 46 to 64 years were followed for an average time of 4.5 years.

RESULTS

In this study population, 192 men (21%) had the D/D genotype; 256 (28%) had the I/I genotype, and 464 (51%) had a heterozygous genotype. In a Cox model adjusting for other coronary risk factors, men with the D/D genotype had 2.2 times (95% confidence interval: 1.1 to 4.4, p = 0.02) the risk to experience an acute coronary event (n = 15 for D/D, 10 for I/I and 12 for I/D) compared with men carrying either of the other two genotypes. The _2B-adrenoceptor genotype was not associated with hypertension in this study population.

CONCLUSIONS

The D/D genotype of the _2B-adrenoceptor is a novel genetic risk factor for acute coronary events, but not for hypertension.

Abbreviations and Acronyms   AMI = acute myocardial infarction   AR = adrenergic receptor   BMI = body mass index   BP = blood pressure   CHD = coronary heart disease   CI = confidence interval   D = deletion   ECG = electrocardiogram   I = insertion   KIHD = Kuopio Ischemic Heart Disease Risk Factor study   LDL = low density lipoprotein   PCR = polymerase chain reaction   RR = relative risk   WHO = World Health Organization

This article has been cited by other articles:

				T. C. Sichrovsky, S. Mittal, and J. S. Steinberg Dexmedetomidine Sedation Leading to Refractory Cardiogenic Shock Anesth. Analg., June 1, 2008; 106(6): 1784 - 1786. [Abstract] [Full Text] [PDF]

				L. C. Duling, T. W. Cherng, J. R. Griego, M. F. Perrine, and N. L. Kanagy Loss of {alpha}2B-adrenoceptors increases magnitude of hypertension following nitric oxide synthase inhibition Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2403 - H2408. [Abstract] [Full Text] [PDF]

				J. P. Etzel, B. K. Rana, G. Wen, R. J. Parmer, N. J. Schork, D. T. O'Connor, and P. A. Insel Genetic Variation at the Human {alpha}2B-Adrenergic Receptor Locus: Role in Blood Pressure Variation and Yohimbine Response Hypertension, June 1, 2005; 45(6): 1207 - 1213. [Abstract] [Full Text] [PDF]

				J J McCarthy, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes J. Med. Genet., May 1, 2004; 41(5): 334 - 341. [Abstract] [Full Text] [PDF]

				S. L. Kirstein and P. A. Insel Autonomic Nervous System Pharmacogenomics: A Progress Report Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52. [Abstract] [Full Text] [PDF]

				F. von Wowern, K. Bengtsson, U. Lindblad, L. Rastam, and O. Melander Functional Variant in the {alpha}2B Adrenoceptor Gene, a Positional Candidate on Chromosome 2, Associates With Hypertension Hypertension, March 1, 2004; 43(3): 592 - 597. [Abstract] [Full Text] [PDF]

				J. O. Ruuskanen, H. Xhaard, A. Marjamaki, E. Salaneck, T. Salminen, Y.-L. Yan, J. H. Postlethwait, M. S. Johnson, D. Larhammar, and M. Scheinin Identification of Duplicated Fourth {alpha}2-Adrenergic Receptor Subtype by Cloning and Mapping of Five Receptor Genes in Zebrafish Mol. Biol. Evol., January 1, 2004; 21(1): 14 - 28. [Abstract] [Full Text] [PDF]

				A. Snapir, J. Mikkelsson, M. Perola, A. Penttila, M. Scheinin, and P. J. Karhunen Variation in the alpha2B-adrenoceptorgene as a risk factor for prehospitalfatal myocardial infarction and sudden cardiac death J. Am. Coll. Cardiol., January 15, 2003; 41(2): 190 - 194. [Abstract] [Full Text] [PDF]

				G. Heusch Emerging importance of alpha-adrenergic coronary vasoconstriction in acute coronary syndromes and its genetic background J. Am. Coll. Cardiol., January 15, 2003; 41(2): 195 - 196. [Full Text] [PDF]

				O. Madsen, D. Willemsen, B. M. Ursing, U. Arnason, and W. W. de Jong Molecular Evolution of the Mammalian Alpha 2B Adrenergic Receptor Mol. Biol. Evol., December 1, 2002; 19(12): 2150 - 2160. [Abstract] [Full Text] [PDF]

				M. Brede, F. Wiesmann, R. Jahns, K. Hadamek, C. Arnolt, S. Neubauer, M. J. Lohse, and L. Hein Feedback Inhibition of Catecholamine Release by Two Different {alpha}2-Adrenoceptor Subtypes Prevents Progression of Heart Failure Circulation, November 5, 2002; 106(19): 2491 - 2496. [Abstract] [Full Text] [PDF]

				M. Philipp, M. Brede, and L. Hein Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R287 - R295. [Abstract] [Full Text] [PDF]

				S. E. LIPSHULTZ, S. D. FISHER, W. W. LAI, and T. L. MILLER Cardiovascular Monitoring and Therapy for HIV-Infected Patients Ann. N.Y. Acad. Sci., November 1, 2001; 946(1): 236 - 273. [Abstract] [Full Text] [PDF]

				G. Heusch, R. Erbel, and W. Siffert Genetic determinants of coronary vasomotor tone in humans Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1465 - H1468. [Full Text] [PDF]